Do you know what extension he's on? <a href=" http://siulodarba.com/data-sets-for-statistics-projects ">personal statement essay for pharmacy</a> PRADAXA is currently approved by the FDA to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF), and was the first oral anticoagulant approved by the FDA in more than 50 years for this indication.